Viking Therapeutics
0 sources
Financials
0001193125-26-046876Viking Therapeutics
Summary
Viking Therapeutics is a business[1].
Key Facts
- Viking Therapeutics is in the country of United States[2].
- Viking Therapeutics is in the country of US[3].
- Viking Therapeutics's instance of is recorded as business[4].
- Viking Therapeutics's headquarters location is recorded as San Diego[5].
- Viking Therapeutics's stock exchange is recorded as Nasdaq[6].
- Viking Therapeutics's industry is recorded as biotechnology industry[7].
- January 1, 2012 marks the founding of Viking Therapeutics[8].
- Viking Therapeutics's official website is recorded as http://www.vikingtherapeutics.com/[9].
- Viking Therapeutics's legal form is recorded as 8888[10].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900IVC72YPFA25M37[11]
-
Registered legal name: Viking Therapeutics,Inc.[12]
-
Legal jurisdiction: US-DE[13]
-
GLEIF entity category: GENERAL[14]
-
Legal form (ISO 20275 ELF): 8888[15]
-
Other legal form: Corporation[16]
-
Entity status: ACTIVE[17]
-
LEI registration status: LAPSED[18]
-
LEI first registered: 2018-11-02[19]
-
LEI last updated: 2021-07-16[20]
-
LEI next renewal: 2019-11-02[21]
-
Managing LOU: 5299000J2N45DDNE4Y28[22]
-
Registration authority: RA000602[23]
-
Authority entity ID: 5217215[24]
-
Conformity flag: NON_CONFORMING[25]
Body
Founding
January 1, 2012 marks the founding of Viking Therapeutics[8].
Operations
Viking Therapeutics's headquarters location is recorded as San Diego[5].
Industry
Viking Therapeutics's industry is recorded as biotechnology industry[7].
Ownership
Viking Therapeutics's stock exchange is recorded as Nasdaq[6].